NEWS: Today we are thrilled to announce the oversubscribed final close of Ada Ventures Fund II at £63m/$80m.
The £63m/$80m fund is dedicated to breakthrough ideas across the fund’s three themes: climate equity, healthy ageing and economic empowerment. We will continue to make pre-seed and seed investments between £250k and £1.5m
And we’re already on our way.
Our investment team has already partnered with 11 new companies across the UK including, BlakBear, Materials Nexus, OPENFORMAT, Juno Bio, PlannerPal, Multiomic Health, Glowb, Boldr, Greenworkx and Radiant Matter.
Our co-founding Partner, Francesca (Check) Warner, said: "We’re thrilled to announce the final close of our second fund. We’ve worked incredibly hard over the last five years to develop the systems and processes to turn our ambition to build a truly diverse and inclusive fund into reality. Strong returns are strongly correlated with inclusive investment. We want other funds to copy this blueprint. The excuse that diverse talent isn’t ‘out there’ is a cop out. We have proven that you can build a thriving, inspiring portfolio of diverse founders building breakthrough products and hugely valuable businesses."
A big thank you to the LPs who joined Ada Ventures Fund II including British Business Bank, The University of Edinburgh, Big Society Capital, Legal & General Capital, Atomico, Export and Investment Fund of Denmark and Molten Ventures. They have been joined by a number of founder investors, including Taavet Hinrikus, co-founder of Wise, and Illusian Family Office, co-founded by Ilkka Paananen, co-founder and CEO of Supercell.
Swipe right to learn more about Fund II's portfolio and follow the story in the comments below 👇
Nuffield Department of Medicine, Centre for Medicines Discovery, University of Oxford. Retiring from all during 2024-25.
1yMany congrats Joanna to you and the team at VisusNano. Many people, not least, and importantly, suffering patients will be listening with much interest to hear of your progress.